The CABB Group will exhibit at CPHI Milan 2026 from 6 to 8 October (Booth 12P47). CPHI is one of the world’s largest trade fairs for the pharmaceutical ingredients industry, bringing together suppliers, manufacturers and buyers from across the global pharma value chain – and a natural setting for CABB to present what it stands for as a leading contract development and manufacturing organization (CDMO).

Complex Chemistry Across the Full Value Chain

The CABB Group specializes in complex and high-purity molecules, covering the full value chain from process development and piloting through scale-up to commercial manufacturing. The synthesis of demanding molecules, multi-step reactions and the specific requirements of regulated pharma environments are at the core of what CABB has been doing for decades – with companies of every size, at every stage.

A European Production Footprint Built for Supply Security

In a market environment shaped by geopolitical uncertainty and the growing importance of supply chain security, the case for a trusted European partner has become structural. Die CABB Group operates four production sites in Germany, Switzerland and Finland – a multi-site European footprint with redundant CDMO manufacturing capabilities and consistent quality standards across locations. Key raw materials are produced in-house, reducing exposure to external supplier disruptions. For companies seeking to reduce their dependence on non-European supply chains or to secure a reliable CDMO partner, the CABB Group’s European presence and long track record in the industry offer a proven basis for partnership.

Meet CABB at CPHI Milan

CPHI is where the pharma industry meets. The CABB Group’s team will be at Booth 12P47 throughout the three days of the fair – available to discuss project requirements, CDMO partnerships and supply chain questions. To arrange a meeting in advance or to learn more about the CABB Group’s products and services, please [email protected]